Brucella Abortus strain RB51 vaccination in elk I. Efficacy of reduced dosage
Bovine brucellosis is a serious zoonotic disease affecting some populations of Rocky Mountain elk (Cervus elaphus nelsoni) and bison (Bison bison) in the Greater Yellowstone Area, USA. The fear that elk and/or bison may spread Brucella abortus to livestock has prompted efforts to reduce or eliminate the disease in wildlife. Brucella abortus strain RB51 (RB51) vaccine has recently been approved for use in cattle. Unlike strain 19 vaccine, RB51 does not cause false positive reactions on standard brucellosis serologic tests. If effective, it may become the vaccine of choice for wildlife. In February 1995, 45 serologically negative female elk calves were trapped and taken to the Sybille Wildlife Research and Conservation Education Unit near Wheatland, Wyoming, USA. In May 1995, 16 of these elk calves were hand-vaccinated with 1 × 109 colony forming units (CFU) of RB51, 16 were vaccinated with 1 × 108 CFU RB51 by biobullet, and 13 were given a saline placebo. The elk were bred in fall of 1996 and they were challenged with 1 × 107 CFU of B. abortus strain 2308 by intraconjunctival inoculation in March 1997. Thirteen (100%) control elk aborted, 14 (88%) hand-vaccinated elk aborted, and 12 (75%) biobullet vaccinated elk aborted or produced nonviable calves. These results suggest that a single dose of 1 × 108 to 1 × 109 CFU RB51 does not provide significant protection against B. abortus induced abortion in elk. However, the vaccine appears to be safe at this dose and additional study may reveal a more effective RB51 vaccine regimen for elk.
Publication Source (Journal or Book title)
Journal of Wildlife Diseases
Cook, W., Williams, E., Thorne, E., Kreeger, T., Stout, G., Bardsley, K., Edwards, H., Schurig, G., Colby, L., Enright, F., & Elzer, P. (2002). Brucella Abortus strain RB51 vaccination in elk I. Efficacy of reduced dosage. Journal of Wildlife Diseases, 38 (1), 18-26. https://doi.org/10.7589/0090-3558-38.1.18